Glial markers, including soluble triggering receptor expressed on myeloid cells 2 (sTREM2) and human chitinase-3 (YKL-40) have shown inconsistent modifications in DLB, both in CSF and in plasma, but nevertheless suggesting different glial activation patterns than in AD [18, 19]. This evidence concerns the gene CHI3L1 and Lewy body dementia.